ABSTRACT
BACKGROUND AND OBJECTIVES: Nonfluent variant primary progressive aphasia (nfvPPA) and primary progressive apraxia of speech (PPAOS) can be precursors to corticobasal syndrome (CBS). Details on their progression remain unclear. We aimed to examine the clinical and neuroimaging evolution of nfvPPA and PPAOS into CBS. METHODS: We conducted a retrospective longitudinal study in 140 nfvPPA or PPAOS patients and applied the consensus criteria for possible and probable CBS for every visit, evaluating limb rigidity, akinesia, limb dystonia, myoclonus, ideomotor apraxia, alien limb phenomenon, and nonverbal oral apraxia (NVOA). Given the association of NVOA with AOS, we also modified the CBS criteria by excluding NVOA and assigned every patient to either a progressors or non-progressors group. We evaluated the frequency of every CBS feature by year from disease onset, and assessed gray and white matter volume loss using SPM12. RESULTS: Asymmetric akinesia, NVOA, and limb apraxia were the most common CBS features that developed; while limb dystonia, myoclonus, and alien limb were rare. Eighty-two patients progressed to possible CBS; only four to probable CBS. nfvPPA and PPAOS had a similar proportion of progressors, although nfvPPA progressed to CBS earlier (p-value = 0.046), driven by an early appearance of limb apraxia (p-value = 0.0041). The non-progressors and progressors both showed premotor/motor cortex involvement at baseline, with spread into prefrontal cortex over time. DISCUSSION: An important proportion of patients with nfvPPA and PPAOS progress to possible CBS, while they rarely develop features of probable CBS even after long follow-up.
Subject(s)
Apraxias , Disease Progression , Primary Progressive Nonfluent Aphasia , Humans , Male , Female , Longitudinal Studies , Aged , Middle Aged , Apraxias/etiology , Apraxias/physiopathology , Apraxias/diagnostic imaging , Retrospective Studies , Primary Progressive Nonfluent Aphasia/physiopathology , Primary Progressive Nonfluent Aphasia/diagnostic imaging , Magnetic Resonance ImagingABSTRACT
Corticobasal syndrome is generally considered to be a sporadic condition. There are familial and isolated genetic cases, associated with GRN, MAPT, c9orf72 or PNRP variants. Some reports implicate other genes: LRRK2, CHMP2B, GBA, CYP27A1, PSEN1, APP, TARDBP and TBK1. Here, we report a case of a patient carrying a SQSTM1 Pro392Leu variant. We report a 57-year-old right-handed-woman with a history of progressive speech impairment, marked right side rigidity and bradykinesia, with rest tremor and stimulus sensitive myoclonus. She had predominantly right-sided apraxia. She had right side agraphestesia and astereognosis. MRI showed asymmetrical left frontotemporoparietal atrophy. DaTSCAN showed predominantly left involvement, PiB-PET was negative. CSF NfL was of 9356.5pg/mL. She carried a heterozygous variant P392L in SQSTM1. This case report expands the spectrum of phenotypes associated with SQSTM1 pathogenic variants. It also expands the list of genes associated with corticobasal syndrome, supporting the involvement of the ubiquitin-proteasome system in this condition.
Subject(s)
Primary Progressive Nonfluent Aphasia , Sequestosome-1 Protein , Humans , Female , Middle Aged , Sequestosome-1 Protein/genetics , Primary Progressive Nonfluent Aphasia/genetics , Corticobasal Degeneration/genetics , Corticobasal Degeneration/complicationsABSTRACT
OBJECTIVES: To examine the clinical trajectories and neural correlates of cognitive and emotion processing changes in the non-fluent/agrammatic (nfvPPA) and the logopenic (lvPPA) variants of primary progressive aphasia (PPA). DESIGN: Observational case-control longitudinal cohort study. SETTING: Research clinic of frontotemporal dementia. PARTICIPANTS: This study recruited 29 non-semantic PPA patients (15 nfvPPA and 14 lvPPA) and compared them with 15 Alzheimer's disease (AD) patients and 14 healthy controls. MEASUREMENTS: Participants completed an annual assessment (median = 2 years; range = 1-5 years) of general cognition, emotion processing and structural MRI. Linear mixed effects models investigated clinical and imaging trajectories between groups. RESULTS: Over time, lvPPA showed the greatest cognitive deterioration. In contrast, nfvPPA showed significant decline in emotion recognition, whereas AD showed preserved emotion recognition, even with disease progression. Importantly, lvPPA also developed emotion processing impairments, with disease progression. Both nfvPPA and lvPPA showed continuing cortical atrophy in hallmark language-processing regions associated with these syndromes, together with progressive involvement of the right hemisphere regions, mirroring left hemisphere atrophy patterns at presentation. Decline in emotion processing was associated with bilateral frontal atrophy in nfvPPA and right temporal atrophy in lvPPA. CONCLUSIONS: Our results show divergent clinical courses in nfvPPA and lvPPA, with rapid cognitive and neural deterioration in lvPPA and emotion processing decline in both groups and support the concurrent assessment of cognition and emotion processing in the clinic to inform diagnosis and monitoring in the non-semantic variants of PPA.
Subject(s)
Alzheimer Disease , Aphasia, Primary Progressive , Primary Progressive Nonfluent Aphasia , Humans , Alzheimer Disease/psychology , Aphasia, Primary Progressive/diagnostic imaging , Aphasia, Primary Progressive/complications , Aphasia, Primary Progressive/psychology , Atrophy , Disease Progression , Emotions , Longitudinal Studies , Primary Progressive Nonfluent Aphasia/complications , Case-Control StudiesABSTRACT
Amygdala atrophy has been found in frontotemporal dementia (FTD), yet the specific changes of its subregions across different FTD phenotypes remain unclear. The aim of this study was to investigate the volumetric alterations of the amygdala subregions in FTD phenotypes and how they evolve with disease progression. Patients clinically diagnosed with behavioral variant FTD (bvFTD) (n = 20), semantic dementia (SD) (n = 20), primary nonfluent aphasia (PNFA) (n = 20), Alzheimer's disease (AD) (n = 20), and 20 matched healthy controls underwent whole brain structural MRI. The patient groups were followed up annually for up to 3.5 years. Amygdala nuclei were segmented using FreeSurfer, corrected by total intracranial volumes, and grouped into the basolateral, superficial, and centromedial subregions. Linear mixed effects models were applied to identify changes in amygdala subregional volumes over time. At baseline, bvFTD, SD, and AD displayed global amygdala volume reduction, whereas amygdala volume appeared to be preserved in PNFA. Asymmetrical amygdala atrophy (left > right) was most pronounced in SD. Longitudinally, SD and PNFA showed greater rates of annual decline in the right basolateral and superficial subregions compared to bvFTD and AD. The findings provide comprehensive insights into the differential impact of FTD pathology on amygdala subregions, revealing distinct atrophy patterns that evolve over disease progression. The characterization of amygdala subregional involvement in FTD and their potential role as biomarkers carry substantial clinical implications.
Subject(s)
Amygdala , Frontotemporal Dementia , Aged , Female , Middle Aged , Alzheimer Disease/pathology , Amygdala/diagnostic imaging , Amygdala/pathology , Atrophy/diagnostic imaging , Atrophy/pathology , Cross-Sectional Studies , Disease Progression , Frontotemporal Dementia/classification , Frontotemporal Dementia/diagnostic imaging , Frontotemporal Dementia/pathology , Frontotemporal Dementia/physiopathology , Longitudinal Studies , Magnetic Resonance Imaging , Organ Size , Primary Progressive Nonfluent Aphasia/pathology , Time Factors , Humans , MaleABSTRACT
Introducción: Entre las enfermedades neurodegenerativas se encuentra un grupo de patologías que se caracterizan por un compromiso prominente del lenguaje, denominadas usualmente afasias primarias progresivas, las cuales se subdividen en 3 tipos: variante logopénica, variante semántica y variante no fluente o agramática. Presentación del caso: Paciente con cuadro clínico que inicia a los 65 años, con disminución en la interacción social. Un par de meses después, la esposa nota que el lenguaje del paciente se torna poco fluido, habla con palabras o frases cortas, no logra decir oraciones completas, además de presentar cambios en la entonación de las palabras y alteraciones del lenguaje escrito. El paciente manifiesta que su principal limitación en el momento es el no poder expresar lo que quiere decir, y por este motivo consulta. Discusión: En el caso de este paciente, se describe inicialmente un cambio en su personalidad que no compromete su funcionalidad, sin embargo, al poco tiempo se presenta compromiso del lenguaje como síntoma prominente y que genera mayor compromiso en su calidad de vida, con pruebas neuropsicológicas y hallazgos de neuroimagen que apoyan el diagnóstico de afasia primaria progresiva (APP) variante no fluente o agramatical, con síntomas comportamentales y motores asociados. Conclusión: Las APP son un grupo de trastornos neurocognitivos cuya característica primordial es el compromiso en el lenguaje, cada variante de APP tiene unas características clínicas y criterios diagnósticos específicos que se deben conocer para lograr sospechar el diagnóstico y hacer un abordaje apropiado en el paciente.
Introduction: In the group of neurodegenerative diseases, there is a group of pathologies that are characterized by a prominent compromise of language, normally called primary progressive aphasias, these are subdivided into 3 types: logopenic variant, semantic variant and non-fluent or agrammatic variant. Case presentation: Patient with a clinical picture that begins at age 65, with decreased social interaction, a couple of months later his wife notices that his language becomes not fluent, speaks in short words or phrases, cannot say complete sentences, in addition to changes in the intonation of words and alterations in written language, the patient states that his main limitation at the moment is not being able to express what he wants to say and for this reason they consult. Discussion: In the case of this patient, a change in his personality is initially described that does not compromise his functionality, however soon after a language involvement is presented as the main symptom and the one that generates a compromise in his quality of life, with neuropsychological tests and findings on neuroimaging that supports the diagnosis of primary progressive aphasia (PPA) non-fluent or agrammatical variant, with associated behavioral and motor symptoms. Conclusion: APPs are a group of neurocognitive disorders whose primary characteristic is language impairment. Each APP variant has specific clinical characteristics and diagnostic criteria that must be known in order to suspect the diagnosis and make an appropriate approach to the patient.
Subject(s)
Neurocognitive Disorders , Dementia , Primary Progressive Nonfluent Aphasia , LanguageABSTRACT
Antecedentes y objetivos: Mucho se ha discutido sobre el uso de la gestualidad en la afasia. Tradicionalmente, los estudios se han centrado en dos aspectos: a)determinar si su empleo se encuentra deteriorado o no en la afasia, y b)si la presencia o ausencia de fluidez tiene alguna influencia en su uso. Sin embargo, en español son pocas las investigaciones que han abordado el estudio de la gestualidad en la afasia y los aspectos antes mencionados. Por tal motivo, el objetivo de esta investigación es analizar el empleo de gestos en cuatro hablantes con afasia para saber si la gestualidad se mantiene a pesar de la patología y para determinar cuál es el papel que desempeña la fluidez en el uso de gestos. Materiales y métodos: Participaron cuatro sujetos con afasia dos con afasia fluida y dos con afasia no fluida, por lo que fueron distribuidos en dos grupos. El estudio fue de tipo descriptivo-exploratorio de las conductas no verbales de los participantes. A cada sujeto se le realizó una entrevista semiestructurada con la intención de promover un índice de participación alto. Se evaluó el tipo y la cantidad de gestos utilizados, considerando la variable fluidez/no fluidez, a partir de las propuestas teóricas de Cosnier (1987) y Ekman (2004), principalmente. Resultados: Se observó que los sujetos con afasia conservan el empleo de gestos; además, los participantes con afasia no fluida emplean más gestos con una alta carga semántica y sin la presencia de habla, mientras que los sujetos con afasia fluida emplean menos gestos y con la presencia de habla. Conclusiones: El habla y los gestos son dos procesos independientes que trabajan en paralelo, por lo que el uso de gestos puede permanecer a pesar de las alteraciones lingüísticas de los hablantes con afasia. Los gestos son empleados como estrategias compensatorias que ayudan a que los hablantes con afasia se comuniquen a pesar de la pérdida del habla.(AU)
Background and objective: Much has been discussed about the use of gestures in aphasia. Mainly, studies have been focused on two aspects: (i)to stablish if gestures are employed normally in aphasia or if there is some loss in this capacity, and (ii)to determine if fluency plays a major role. However, in Spanish there are few researches which has tackle study about gestuality in aphasia and the two aspects mentioned before. For this reason, the aim of this study is analyzing the use of gestures in four aphasic-speakers to figure out if gestuality remains despite pathology, and determine what role plays the fluency in the use of gestures. Materials and methods: A descriptive-exploratory study of four subjects with aphasia has been carried out: two with fluent aphasia and two with non-fluent aphasia. A semi-structured interview was conducted with each subject in order to obtain a high participation rate. The type and amount of gestures used were evaluated from the theoretical proposals of Cosnier (1987) and Ekman (2004) mainly, and considering the fluency/non-fluency variable. Results: Both groups employ gestures, but non-fluent subjects use more gestures with a high semantic content and with no speech, meanwhile fluent speakers use less gestures and accompanied of speech. Conclusions: Speech and gestures are two independent processes working in parallel, and gestures are utilized as compensatory strategies which help to speakers with aphasia to communicate despite loss of speech.(AU)
Subject(s)
Humans , Male , Aphasia , Gestures , Nonverbal Communication , Primary Progressive Nonfluent Aphasia , Language Disorders , Communication Disorders , Speech , Language , Speech, Language and Hearing SciencesABSTRACT
BACKGROUND AND PURPOSE: To analyze 18F-THK5351 positron emission tomography (PET) scans of patients with clinically diagnosed nonfluent/agrammatic variant primary progressive aphasia (navPPA). METHODS: Thirty-one participants, including those with Alzheimer's disease (AD, n=13), navPPA (n=3), and those with normal control (NC, n=15) who completed 3 Tesla magnetic resonance imaging, 18F-THK5351 PET scans, and detailed neuropsychological tests, were included. Voxel-based and region of interest (ROI)-based analyses were performed to evaluate retention of 18F-THK5351 in navPPA patients. RESULTS: In ROI-based analysis, patients with navPPA had higher levels of THK retention in the Broca's area, bilateral inferior frontal lobes, bilateral precentral gyri, and bilateral basal ganglia. Patients with navPPA showed higher levels of THK retention in bilateral frontal lobes (mainly left side) compared than NC in voxel-wise analysis. CONCLUSIONS: In our study, THK retention in navPPA patients was mainly distributed at the frontal region which was well correlated with functional-radiological distribution of navPPA. Our results suggest that tau PET imaging could be a supportive tool for diagnosis of navPPA in combination with a clinical history.
Subject(s)
Humans , Alzheimer Disease , Aphasia, Primary Progressive , Basal Ganglia , Broca Area , Diagnosis , Frontal Lobe , Magnetic Resonance Imaging , Neurofibrillary Tangles , Neuropsychological Tests , Positron-Emission Tomography , Primary Progressive Nonfluent Aphasia , tau ProteinsABSTRACT
La Degeneración Lobar Frontotemporal (DLFT) es una entidad neurodegenerativa heterogénea que abarca varios síndromes clínicos diferenciados según su fenotipo, el cual viene determinado por la distribución neuropatológica inicial (frontal o bien temporal), y en los que una alteración progresiva del lenguaje es un hallazgo fundamental. Esto es así especialmente en la variante temporal de la DLFT que también se conoce como Afasia Progresiva Primaria (APP), y que tiende a presentar neuropatología de complejo Pick/Demencia Frontotemporal, o bien de enfermedad de Alzheimer. La APP se caracteriza por debutar con una alteración progresiva del lenguaje que causa un trastorno de la funcionalidad, y con una conservación inicial de otras funciones cognitivas. Aunque los pacientes con APP suelen ser derivados a neurólogos, es importante que los psicogeriatras, y especialmente aquéllos que trabajan con pacientes con demencia, estén familiarizados con este síndrome y que sepan valorar de forma adecuada el lenguaje como función cognitiva. Los pacientes con APP suelen también presentar trastornos de naturaleza neuroconductual y psiquiátrica, y por esta razón, el rol del psicogeriatra será fundamental en su valoración y su tratamiento
Complaints about poor memory and cognitive function found not to be due to dementia are common in the general population, and they are a reason for consultation in primary care and of referrals to specialist services. This could increase the risk of overdiagnosing dementia in a proportion of patients. Various clinical entities that present with mild to moderate memory dysfunction and their possible pathophysiological mechanisms are reviewed in this paper, with the aim to assist the clinician in the differential diagnosis, the consideration of their risk of conversion to dementia, and in deciding on their best possible management
Subject(s)
Humans , Aged , Aphasia, Primary Progressive/diagnosis , Frontotemporal Lobar Degeneration/diagnosis , Neurodegenerative Diseases/diagnosis , Alzheimer Disease/diagnosis , Primary Progressive Nonfluent Aphasia/diagnosis , Language Disorders/etiology , Geriatric Assessment/methodsABSTRACT
Frontotemporal dementia (FTD) is a degenerative disease characterized by the selective frontal and temporal lobe atrophy, and progressive deficits in behavior, executive function, or language. The prevalence and incidence of FTD are 15-22/100000 and 2.7-4.1/100000, respectively, in midlife. Hereditary is an important risk factor for FTD. Although there is some controversy regarding the further syndromatic subdivision of the different types of FTD, FTD is clinically classified into behavioral variant of frontotemporal dementia, semantic dementia and progressive nonfluent aphasia. FTD can be misdiagnosed as many psychiatric disorders because of similarity of the prominent behavioral features. Advances in clinical, imaging, and molecular characterization have increased the accuracy of FTD diagnosis, thus developing for the accurate differentiation of these syndromes from psychiatric disorders. We also discuss about therapeutic strategies for symptom management of FTD. Medications such as serotonin reuptake inhibitors, antipsychotics, and other novel treatments have been used in FTD with various rates of success. Further advanced research should be directed at understanding and developing new diagnostic and therapeutic modalities to improve the FTD patients' prognosis and quality of life.
Subject(s)
Antipsychotic Agents , Atrophy , Diagnosis , Drug Therapy , Executive Function , Frontotemporal Dementia , Genetics , Incidence , Prevalence , Primary Progressive Nonfluent Aphasia , Prognosis , Quality of Life , Risk Factors , Selective Serotonin Reuptake Inhibitors , Temporal LobeABSTRACT
No disponible
Subject(s)
Female , Humans , Middle Aged , Primary Progressive Nonfluent Aphasia/complications , Primary Progressive Nonfluent Aphasia/diagnosis , Parkinson Disease/complications , Parkinson Disease/diagnosis , Alzheimer Disease/complications , Dementia/complications , Dementia/diagnosis , Biomarkers , Hypokinesia/complications , Neuropsychology/methods , Neuropsychology/trends , Positron-Emission Tomography/methodsABSTRACT
The aim of this paper is to analyze the effects of intensive speech therapy intervention in a case of progressive non-fluent aphasia (PNFA). This is a dementia syndrome characterized by a progressive deficit in expressive language fluency and syntactic analysis, and by agrammatism and phonemic paraphasias. Although in the early stages there are no alterations in memory, comprehension, or visual processing, personality changes can slightly occur. To analyze the effects of speech therapy in this syndrome, a single case design with pre- and post-test was used. The participant was a male patient of 84 years with PNFA, who for twelve months received weekly speech therapy to stimulate the phonological, lexical and syntactic processing. He underwent neuropsychological assessment in three stages: six months before the onset of therapy, six months after therapy started and after completing 12 months of intervention. Assessment involved linguistic processing, general cognition, neuropsychiatric symptoms, quality of life (QOL) and activities of daily living (ADL). As a result of therapy, the patient showed a slight improvement in language prosody, fluency, and content of spontaneous speech, and a significant improvement in repetition, reading aloud, and oral-phonatory praxis. Other aspects of cognitive functioning (orientation, verbal naming, praxis, and memory) remained stable; ADLs and QOL improved. It is concluded that prolonged speech therapy can improve language processing and have a positive impact on other cognitive and socio-emotional processes in PNFA. This 12-month therapeutic stimulation not only slowed cognitive decline, but allowed to see maintenance of achievements and improvement of symptoms, which can be regarded as a success in PNFA treatment, considering the rapid progression of the disease.
El objetivo de este artículo es analizar los efectos de una intervención intensiva de terapia del lenguaje en un caso de afasia progresiva no fluente (APNF). Este es un síndrome demencial caracterizado por un déficit progresivo en la fluidez del lenguaje expresivo y el análisis sintáctico, y por agramatismo y parafasias fonémicas. Aunque en las primeras etapas no presenta alteraciones en la memoria, la comprensión o el procesamiento visual, sí pueden presentarse ligeros cambios en la personalidad. Para analizar los efectos de la terapia del lenguaje en este síndrome, se utilizó un diseño de caso único con pre y post prueba. El participante fue un paciente masculino de 84 años con APNF, quien durante doce meses recibió una terapia de lenguaje semanal para estimular el procesamiento fonológico, léxico y sintáctico. Se le realizó una evaluación neuropsicológica en tres etapas: seis meses antes del inicio de la terapia, después de seis meses de intervención, y al completar 12 meses de esta. Específicamente se evaluó el procesamiento lingüístico, la cognición general, los síntomas neuropsiquiátricos, la calidad de vida (CdV) y las actividades de la vida diaria (AVD). Como resultado de la terapia, el paciente mostró ligeras mejorías en la prosodia, la fluidez y el contenido del lenguaje espontáneo, y una mejoría significativa en la repetición, la lectura en voz alta y las praxias orofonatorias. Otros aspectos cognitivos (orientación, denominación verbal, praxias y memoria) se mantuvieron estables; las AVD y la CDV mejoraron. Se concluye que la terapia del lenguaje prolongada puede mejorar el procesamiento lingüístico y también tener un impacto positivo en otros procesos cognitivos y socio-emocionales en la APNF. La intervención no solo disminuyó la velocidad del deterioro cognitivo, sino que permitió ver el mantenimiento de los logros y la mejoría de los síntomas, lo cual es un éxito en el tratamiento de la APNF, debido a su rápida progresión.
O objetivo deste artigo é analisar os efeitos de uma intervenção intensiva de terapia da linguagem em um caso de afasia progressiva não fluente (APNF). Esta é uma síndrome demencial caracterizada por um déficit progressivo na fluência da linguagem expressiva e da análise sintática, e por agramatismo e parafasias fonêmicas. Ainda que nas primeiras etapas não presenta alterações na memória, na compreensão ou no processamento visual, podem aparecer pequenas mudanças na personalidade. Para analisar os efeitos da terapia da linguagem nesta síndrome, utilizou-se um desenho de caso único com testes antes e depois. O participante foi um paciente masculino de 84 anos com APNF, que durante doze meses recebeu uma terapia de linguagem semanal para estimular o processamento fonológico, léxico e sintático. Realizou-se uma avaliação neuropsicológica em três etapas: seis meses antes do início da terapia, depois de seis meses de intervenção, e ao completar 12 meses desta. Avaliou-se especificamente o processamento linguístico, a cognição geral, os sintomas neuropsiquiátricos, a qualidade de vida (QdV) e as atividades da vida diária (AVD). Como resultado da terapia, o paciente mostrou pequenas melhorias na prosódia, na fluência e no conteúdo da linguagem espontânea, e uma melhoria significativa na repetição, na leitura em voz alta e nas praxias orofonatórias. Outros aspectos cognitivos (orientação, denominação verbal, praxias e memória) mantiveram-se estáveis; as AVD e a QdV melhoraram. Conclui-se que a terapia da linguagem prolongada pode melhorar o processamento linguístico e também ter um impacto positivo em outros processos cognitivos e sócio emocionais na APNF. A intervenção diminuiu não somente a velocidade da deterioração cognitiva, senão que permitiu ver a manutenção dos êxitos e a melhoria dos sintomas, o que representa um sucesso no tratamento da APNF, devido a sua rápida progressão.
Subject(s)
Rehabilitation of Speech and Language Disorders , Aphasia, Primary Progressive , Primary Progressive Nonfluent Aphasia , Frontotemporal DementiaABSTRACT
Introdução: A demência frontotemporal (DFT) inclui a variante comportamental da demência frontotemporal (vcDFT), a variante semântica da afasia progressiva primária (vsAPP), e a variante não fluente da APP (vnfAPP). Os genes em que são encontradas mutações causadoras de DFT mais frequentemente são: GRN (que codifica a progranulina), MAPT (que codifica a proteína tau) e C9orf72. Métodos: Foram incluídos probandos diagnosticados com vcDFT, vsAPP ou vnfAPP, com base com os critérios diagnósticos mais recentes, e um grupo de indivíduos cognitivamente normais. Os éxons 2-12 de GRN e os éxons 1, 9-13 de MAPT foram sequenciados pelo método de Sanger, e foi realizada dosagem de progranulina no plasma. Resultados: foram incluídos 62 probandos, sendo 44 com vcDFT, 9 com vsAPP, e 9 com vnfAPP. Antecedente familiar de demência foi positivo em 45,1% dos probandos, e de DFT, em 24,1%. Os 60 indivíduos do grupo controle tinham idade média de 60,8±8,5 anos. Foram identificadas seis mutações nulas em GRN (p.Q130X, p.V200Gfs*18, p.Q257Pfs*26, p.Q300X, p.S301Cfs*60 e p.D317Afs*11) e uma mutação patogênica em MAPT (p.N279K). A dosagem média de progranulina plasmática nos pacientes com mutações de GRN foi de 29,8±11,9ng/ml Conclusões: A frequência de mutações patogênicas em GRN nesta casuística foi de 9,6%, e a de mutações em MAPT foi de 1,6%. Entre casos familiais de DFT, a frequência de mutações em GRN foi de 33,3%, e em MAPT foi de 6,7%. Duas das mutações encontradas em GRN (p.Q130X e p.D317Afs*11) ainda não foram descritas em casos de DFT. O valor de corte de 70ng/ml identificou as mutações nulas de GRN com sensibilidade e especificidade de 100%.
Introduction: Frontotemporal dementia (FTD) encompasses behavioral variant of frontotemporal dementia (bvFTD), semantic variant of primary progressive aphasia (svPPA), and nonfluent variant PPA (nfvPPA). The genes in which FTD-causing mutations are most frequently found are: GRN (which encodes progranulin), MAPT (which encodes tau protein) and C9orf72. Methods: We included probands diagnosed with bvFTD, svPPA or nfvPPA, based on the most recent diagnostic criteria, and a group of cognitively normal individuals. GRN exons 2-12 and MAPT exons 1, 9-13 were sequenced by the Sanger method, and plasma progranulin levels were measured. Results: we included 62 probands (44 with bvFTD, 9 with svPPA, and 9 with nfvPPA). Family history of dementia was positive in 45.1% of probands, and of DFT, in 24.1%. The control group of 60 individuals had a mean age of 60.8±8.5 years. Six null GRN mutations were identified in (p.Q130X, p.V200Gfs*18, p.Q257Pfs*26, p.Q300X, p.S301Cfs*60 e p.D317Afs*11) and one MAPT pathogenic mutation (p.N279K). The mean plasma progranulin level in patients with GRN mutations was 29.8±11,9ng/ml. Conclusions: The frequency of pathogenic mutations in GRN was 9.6%, and of MAPT mutations was 1.6%. Among cases of familial FTD, the frequency of GRN mutations was 33.3%, and of MAPT mutations was 6.7%. Two of the mutations found in GRN (p.Q130X and p.D317Afs*11) are novel. The cutoff value of 70ng/ml identified null GRN mutations with sensitivity and specificity of 100%.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Frontotemporal Dementia , Frontotemporal Lobar Degeneration , Genetics , Mutation , Primary Progressive Nonfluent Aphasia , TauopathiesABSTRACT
Purpose To investigate and to compare quality of life (QOL) in fluent and non-fluent aphasics. Methods This is a prospective, quantitative, and transversal study. We included 11 stroke patients with aphasia (five non-fluent aphasics augmentative and alternative communication users and six fluent aphasics). Data was gathered from the Stroke Specific Quality of Life Scale (SS-QOL), a structure interview, and The Modified Rankin Scale. Results The non-fluent aphasics presented poorer Rankin and quality of life than the fluent aphasics. The major difference occurred in the fields of language and upper extremity function. The three most affected domains in non-fluent aphasics were language, social roles, and thinking, whereas in the fluent aphasics were personality, social roles, and thinking. All the subjects referred a worse quality of life after stroke. The domains of language and self-care were identified as the most affected after stroke. Conclusion This study demonstrated that, in general, non-fluent aphasics have lower quality of life than fluent aphasics. However, this difference is not homogeneous among the several quality of life domains. Additionally, this research evidences a relationship between aphasia severity and individual functionality, implying impairment in quality of life, especially for non-fluent aphasics. .
Objetivo Investigar e comparar a qualidade de vida de afásicos fluentes e não fluentes. Métodos Trata-se de pesquisa prospectiva, quantitativa, transversal, cuja amostra se constituiu de 11 sujeitos afásicos (5 não fluentes, usuários de comunicação suplementar e/ou alternativa e 6 fluentes, não usuários de comunicação suplementar e/ou alternativa. A coleta de dados foi realizada por meio da aplicação de um questionário específico de qualidade de vida, entrevista estruturada e aplicação da escala de Rankin modificada. Resultados Na comparação dos grupos estudados, os afásicos não fluentes apresentaram escores de Rankin e de qualidade de vida menores do que os fluentes e as maiores diferenças referiram-se aos domínios de linguagem e função do membro superior. Os domínios mais prejudicados pelo acidente vascular cerebral foram linguagem, relações sociais e modo de pensar, para os afásicos não fluentes, e comportamento, relações sociais e modo de pensar, para os fluentes. Todos os sujeitos relataram que sua qualidade de vida piorou após o acidente vascular cerebral, sendo que linguagem e cuidados pessoais foram apontados como os aspectos que mais mudaram, após o episódio lesional. Conclusão Os achados mostram relação entre gravidade da afasia e funcionalidade do indivíduo, indicando que, no geral, os afásicos não fluentes apresentam qualidade de vida pior do que os fluentes. As diferenças não são homogêneas nos diversos domínios de qualidade de vida. .
Subject(s)
Humans , Aphasia, Primary Progressive , Communication Aids for Disabled , Health-Disease Process , Primary Progressive Nonfluent Aphasia , Quality of Life , Stroke , Case-Control Studies , Epidemiologic Factors , Health Promotion , Sickness Impact ProfileABSTRACT
OBJETIVO: Caracterizar os fatores gênero, idade, tempo de duração e tipologia das disfluências, fatores estressantes físicos e emocionais em crianças com alto risco para a gagueira e com recorrência familial do distúrbio. MÉTODOS: Participaram 65 crianças com alto risco para a gagueira desenvolvimental familial, de ambos os gêneros, na faixa etária de três a 11anos. A coleta de dados foi realizada por meio do Protocolo de Risco para a Gagueira do Desenvolvimento (PRGD). RESULTADOS: A razão masculino/feminino de crianças disfluentes encontrada foi de 2,8:1, com predominância do grupo na faixa etária de três anos. Os resultados revelaram diferença significativa quanto ao tempo de duração: mais crianças apresentaram um período maior de 12 meses de duração das disfluências em relação às crianças que apresentaram de seis a 12 meses de duração. A maioria apresentou algum fator estressante emocional e não apresentou fator estressante físico. CONCLUSÃO: Os resultados sugerem que crianças com recorrência familial da gagueira no gênero masculino, na faixa etária de três anos, com presença de disfluências gagas por mais de 12 meses e com ocorrência de fatores estressantes emocionais são as que apresentam maior risco para o desenvolvimento da gagueira persistente.
PURPOSE: To characterize the factors gender, age, duration and typology of the disfluencies; physical and emotional stresses in children with high risk for stuttering and with familial recurrence of the disorder. METHODS: Sixty-five children with high risk for developmental familial stuttering of both genders, with ages between 3 and 11 years and 11 months. The data were gathered through the Protocol of Risk for the Developmental Stuttering. RESULTS: In our findings the ratio male:female was 2.8:1, and the majority of the children were aged 3 years old. Significantly more children presented more than 12 months' duration of the disfluencies when compared to children that presented 6 to 12 months' duration. The majority showed some emotional stress and didn't show any physical stress. CONCLUSION: The results of this study suggest that children with familial recurrence of stuttering, male, with 3 years old, with stuttering-like disfluencies (SLD) lasting for more than 12 months and with the occurrence of emotional stresses are the children that present the higher risk for the development of the persistent stuttering.
Subject(s)
Humans , Child, Preschool , Child , Primary Progressive Nonfluent Aphasia , Speech Disorders , Speech, Language and Hearing Sciences/methods , Stuttering/etiology , Stuttering/genetics , Risk FactorsABSTRACT
Introducción. La parálisis supranuclear progresiva (PSP) es una enfermedad neurodegenerativa que se describió por primera vez en 1964 y en la que se produce una acumulación citoplasmática de proteína tau asociada a microtúbulos (MAPT) como consecuencia de su fosforilación anómala. Objetivo. El objetivo de este trabajo ha sido revisar los avances en el conocimiento de la PSP en los últimos años. Desarrollo. La PSP es la taupatía más frecuente, de aparición esporádica pero con algunos casos hereditarios por mutaciones en el gen MAPT. Las manifestaciones clínicas más características de esta enfermedad consisten en inestabilidad postural con caídas, deterioro cognitivo y parálisis supranuclear de la mirada. Se han descrito distintas variantes clínicas, entre las que destacan el Síndrome de Richardson, la PSP- Parkinsonismo, la acinesia pura con congelación de la marcha, la PSP-corticobasal y la afasia no fluente progresiva. Las diferentes características clínicas de estos subtipos vienen determinadas por la distinta densidad y localización de los agregados tau. El diagnóstico definitivo se realiza mediante confirmación anatomopatológica postmortem. Aunque se han producido algunos ensayos terapéuticos, en la actualidad no se dispone de tratamiento eficaz modificador de la enfermedad. Conclusiones. Los recientes avances han permitido un mejor conocimiento de la fisiopatología y genética de esta enfermedad. Existen distintas líneas de investigación abiertas en la actualidad siendo necesario que se profundice en estudios dirigidos a descubrir marcadores biológicos y agentes terapéuticos (AU)
Introduction. Progressive supranuclear palsy (PSP) is a neurodegenerative disease that was first reported in 1964 and which entails a cytoplasmic accumulation of microtubule-associated protein tau (MAPT) as a consequence of its abnormal phosphorylation. Aims. The objective of this research is to review the advances produced in the knowledge of PSP in recent years. Development. PSP is the most frequent tauopathy, which appears sporadically but with some hereditary cases due to mutations in the MAPT gene. The most characteristic clinical manifestations of this disease consist in postural instability with falls, cognitive impairment and supranuclear gaze palsy. Several different clinical variants have been described, including Richardsons syndrome, Parkinsonism-PSP, pure akinesia with freezing of gait, corticobasal-PSP and progressive non-fluent aphasia. The different clinical features of these subtypes are determined by the different density and location of the tau aggregates. The definitive diagnosis is reached by confirmation from post-mortem pathological analyses. Although some therapeutic trials have been conducted, today there is still no effective disease-modifying treatment available. Conclusions. Recent advances have made it possible to gain a better understanding of the pathophysiology and genetics of this disease. Different lines of research are currently open, but there is a need for further in-depth studies aimed at discovering biological markers and therapeutic agents (AU)
Subject(s)
Humans , Male , Female , Bulbar Palsy, Progressive/genetics , Phosphorylation/genetics , Primary Progressive Nonfluent Aphasia/genetics , Levodopa/administration & dosage , Photophobia/metabolism , Blepharospasm/diagnosis , Tauopathies/genetics , Bulbar Palsy, Progressive/pathology , Phosphorylation/physiology , Primary Progressive Nonfluent Aphasia/metabolism , Levodopa/genetics , Photophobia/complications , Blepharospasm/complications , Tauopathies/metabolismABSTRACT
We report a case of a 67-year-old woman with frontotemporal dementia (FTD) and a history of neurocysticercosis. After her retirement she showed progressive behavioral changes and neuropsychiatric symptoms with relative preservation ofcognitive functioning. During the next three years, the patient manifested progressive deterioration of verbal communication gradually evolving to mutism, a hall mark of cases of progressive nonfluent aphasia.
Caso de uma mulher de 71 anos com demência frontotemporal e historia de neurocisticercose. Após sua aposentadoria ela apresentou progressivas mudanças comportamentais e sintomas neuropsiquiátricos, com relativa preservação do funcionamento cognitivo. Durante os seguintes três anos, a paciente foi desenvolvendo uma deteriorização progressiva da comunicação verbal evoluindo gradualmente a mutismo, marca que descreve um caso de afasia progressiva não fluente.
Subject(s)
Humans , Neurocysticercosis , Primary Progressive Nonfluent Aphasia , Frontotemporal Lobar Degeneration , Neuropsychological TestsABSTRACT
Frontotemporal dementia (FTD), formerly called Pick's disease, is a progressive dementia that is associated with focal atrophy of the frontal and/or temporal lobes. FTD has three major clinical subtypes ; 1) a frontal variant of frontotemporal dementia (fvFTD), 2) semantic dementia (SD), and 3) progressive nonfluent aphasia (PNFA). These different variants differ in their clinical symptoms, cognitive deficits, and affected brain regions. The insidious onset of personality changes and behavioral abnormalities is the most prominent feature of fvFTD. Poor insight, loss of personal and social awareness, and blunting of affect are common behavioral changes in fvFTD. The most common presenting complaint in SD involves language, and is often described as a loss of memory for words or a loss of word meaning. Patients with PNFA present with changes in fluency, pronunciation, or word finding difficulty. An accumulating body of evidence suggests that FTD overlaps with three other neurodegenerative diseases: motor neuron disease (MND), corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP). Treatment for FTD consists of behavioral and pharmacological approaches. Medications such as selective serotonin reuptake inhibitors, antipsychotics have used in FTD. Cholinesterase inhibitors do not consistently improve cognitive and behavioral symptoms of FTD. Further research should be directed at developing new therapeutic methods to improve the patients' symptoms.
Subject(s)
Humans , Antipsychotic Agents , Atrophy , Behavioral Symptoms , Brain , Cholinesterase Inhibitors , Dementia , Frontotemporal Dementia , Frontotemporal Lobar Degeneration , Memory , Motor Neuron Disease , Neurobehavioral Manifestations , Pick Disease of the Brain , Primary Progressive Nonfluent Aphasia , Selective Serotonin Reuptake Inhibitors , Supranuclear Palsy, Progressive , Temporal LobeABSTRACT
A woman developed a slowly progressive speech disturbance at age 51. Three years latter she showed difficulty in calculation, reading and writing. At age 57, she complained of right shoulder pain. At age 58, neurological examination revealed rigidity, bradykinesia and ideomotor apraxia in the right upper extremity. This case demonstrats a clinical overlap between progressive nonfluent aphasia and corticobasal degeneration.
Subject(s)
Female , Humans , Apraxia, Ideomotor , Hypokinesia , Neurologic Examination , Primary Progressive Nonfluent Aphasia , Shoulder Pain , Upper Extremity , WritingABSTRACT
Frontotemporal lobar degeneration (FTLD) is a progressive dementia with prominent neuropsychiatric features, aphasia or both. FTLD predominantly affects the frontal and anterior part of temporal cortex. FTLD is classified into frontotemporal dementia (FTD), progressive nonfluent aphasia (PA), and semantic dementia (SD). FTLD is estimated to account for 20% of cases of degenerative dementia with presenile onset. This disease typically has onset in the mid- or early fifties. FTD is characterized by behavioral change and executive dysfunction, PA features a progressive nonfluent aphasia. SD is characterized by a progressive semantic aphasia and associative agnosia. Structural imaging shows atrophy of the frontal lobe and the anterior portion of the temporal lobe, bilaterally symmetric or asymmetric. Pathologically, FTLD can be classified into tau-positive pathology, tau-negative, ubiquitin positive pathology, dementia lacking distinctive histology. At present, there are no specific pharmacological therapies approved for use in any of the FTLD syndrome.
Subject(s)
Agnosia , Aphasia , Atrophy , Dementia , Frontal Lobe , Frontotemporal Dementia , Frontotemporal Lobar Degeneration , Pathology , Primary Progressive Nonfluent Aphasia , Temporal Lobe , UbiquitinABSTRACT
It is not uncommon for idiopathic parkinson's disease (IPD) to occur concurrently with other degenerative dementing disorders such as Alzheimer's disease. However, there has been no report about the comorbidity of IPD and frontotemporal lobar degeneration. We report a 70-year-old man diagnosed with IPD accompanied by progressive non-fluent aphasia (PA). Brain MRI showed left frontal opercular atrophy, and an 18F-FDG PET scan revealed predominant left frontotemporal hypometabolism. It remains unknown whether or not the co-occurrence of IPD and PA was coincidental.